• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Dr. Reddy’s launches extended-release rival to $200M Pfizer drug

cafead

Administrator
Staff member
  • cafead   Jul 11, 2022 at 06:12: PM
via Dr. Reddy's Laboratories is gunning for Pfizer’s extended-release overactive bladder treatment Toviaz, introducing a therapeutic generic equivalent that could threaten more than $200 million in revenues.

article source
 

<